ReNeuron interim loss narrows on lower costs; eyes partnerships
ReNeuron Group PLC on Wednesday reported a slight narrowing in interim loss as costs decreased, as it highlighted its focus on its exosome delivery platform. The Brigdend, Wales-based stem cell and...